In addition, REGENXBIO in collaboration with AbbVie announced in January that a global Phase 3 Clinical Program in diabetic retinopathy ... their Phase 2 ALTITUDE suprachoroidal trial is currently ...

So ALTITUDE, our diabetic retinopathy study ... where you don't see with other programs high microdystrophin levels. So we're really excited about that. But we really want to treat broadly ...

ABBV-RGX-314 which is being developed in collaboration with AbbVie to treat wet AMD and diabetic retinopathy or DR. I'll start with 314 for DR. Being evaluated in the phase two altitude trial ...

RGX-314’s partnership with AbbVie could yield $500 million in milestones, focusing on diabetic retinopathy and wet AMD ... But, yes, maybe just a high level overview of your programs and then we can ...

In people not adapted to life at altitude, the sparse oxygen can impair fetal growth, causing issues that can last a lifetime ...

Traveling at high altitude can be hazardous. The information provided here is designed for educational use only and is not a substitute for specific training or experience. Princeton University and ...

CNBC Select will update as changes are made public. With a high-yield savings account, you can get a solid interest rate and your money grows even faster thanks to compound interest — which lets ...

You might develop high potassium levels while taking 20 mg per day. In this case, your dosage will likely be reduced to 20 mg taken every other day. For adults with excessive aldosterone secretion ...

Taylor Tepper covered banking, investing and pretty much everything else in personal finance for more than a decade, with his work appearing in the New York Times, Fortune and MONEY magazine, as ...